Outcome of Board Meeting held on 05.11.2026

ANANTH BIOORGANICS LIMITED (Formerly Known as GAYATRI BIOORGANICS LIMITED) CIN: L24110TG1991PLC013512 Reg. Ofc: B3, 3rd Floor, 6-3-1090, TSR Towers, Raj Bhavan Road, Somajiguda, Hyderabad – 500082, Telangana Website: www.ananthbio.com Email: info@gayatribioorganics.com Tel: +91 40 6610 0111/66100222 Fax: +91 40 6610 0333 To, Date: 05.11.2026 BSE Limited, P.J. Towers, Dalal Street, Mumbai-400001 Sub: Outcome of Board Meeting held on 05.11.2026 under Regulations 30 read with 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Ref: Board Meeting Intimation dated 02.11.2026 Unit: Ananth Bioorganics Limited (Formerly Known as Gayatri BioOrganics Limited) (Scrip code: 524564) Dear Sir/ Madam, With reference to the above mentioned subject, this is to inform the Exchange that the Board of Directors of Ananth Bioorganics Limited in its meeting held on Thursday, 05.11.2026 at the registered office of the Company, inter-alia, considered and approved the following items: 1. Un-audited financial results for the quarter and half year ended September, 30, 2026 along with the Limited review report as provided by the statutory auditors. (enclosed) The Board meeting commenced at 06:30 p.m. and concluded at 08:10 p.m. This is for the information and records of the Exchange, please. Thanking you. Yours sincerely, For Ananth Bioorganics Limited (Formerly Known as Gayatri Bioorganics Limited) Sreedhara Reddy Kanaparthi Chairman and Managing Director (DIN: 09608890) Encl: as above ANANTH BIOORGANICS LIMITED (Formerly known as Gayatri Bioorganics Limited) Registered office: 83, Third floor, 6-3-1090, TSR Towers, Raj Bhavan Road, Somajiguda, Hyderabad - 500 082 Website: www.ananthbio.com, E mail : info@gayatibioorganics.com crN: L241 lOTGl 991PLCO13512 Tel: +91 40661001 l1l66100222 Fax: +914066100333 STATEMENT OF ASSETS AND LIABILITIES AS AT SEPTEMBER 30,2026 (t In Lakhsl Sr. Particulars As at Sept 30 As at March 3l No. 2026 2026 (Unaudited) (Audited) t. ASSETS I Non-Current Assets (a) Financial assets (i) Investments (ii) Other Financial Assets 2 Current Assets (a) FinancialAssets (i) Trade Receivables s8.63 25.36 (ii) Cash and Cash equivalents 2.52 2.00 (iii) Other Financial Assets (b) Other Current assets 142.55 144.39 203.70 171.75 TOTAL ASSETS 203;.70 t7r,75, EQUITIES AND LIABILITIES EQUITY (a) Equity Share Capital 7,878.81 7,878.81 (b) Other Equity (l1,584.611 (11,579.31 (3,705.80) (3,700.49) LIABILITIES 2 Non-Current Liabilities (a) Financial Liabilities (i) Borrowings 3,754.46 3,523.14 3,754.46 3,523.14 J Current Liabilities (a) Financial Liabilities (i) Borrowings l',|4.40 (ii) Trade Payables 48.52 16.69 (b) Other Current liabilities 106.52 15 8.01 155.04 349.10 TOTAL EQUITY AND LIABILITIES -^- 203.70 19,L,75 f 't'*+ r'iN ANANTH BIOORGANICS LIMITED (Formerly known as Gayatri Bioorganics Limited) Registered office: 83, Third floor, 6-3-1 090, TSR Towers, Raj BhavanR.oad, Somajiguda, Hyderabad - 500 082 Website: www. ananthbio. com, E mail info@gayatribioorganics. com CIN: L24l lOTGl 991PLC013512 Tel: +914066100111166100222 Fax :+9140 6610 0333 Statement of Cash Flow (t in Lakhs unless otherwise stated) As at As at 30.09.2026 Particulars (Un-Audited) 30.09.2025 (Un-Audited) A. Cash Flow from Operating Activities (Loss) before tax (s.30) (47.42 Adjustments for: - Tax Expenses - Finance Costs Operating Profit Before Working Capital Changes (s.30t (47.42) Changes in operating assets and liabilities: (lncrease) / Decrease in Operating Assets: - Non-current Financial Assets & Other Assets (33.27" - Other current assets 1.84 0.58 Increase / (Decrease) in Operating Liabilities: - Trade Payables 31.83 (1.41) - Other Current Liabilities (s 1.49' 9.89 Cash (used in) / generated from Operations (s6.39 (38.36) - Direct Taxes paid 'I3fl,36) Nct cash (used in) Operating Activities (A) (s6.J9 B. Cash Flow from Investinq Activities - Interest Received Net crsh flow (used in) investing activities (B) C. Cash Flow from Financing Activities - Proceeds from Bonowings (Net) 231.32 30.53 - lnterest and Finance Charges paid - lncrease in Cunent Borrowings (174.40' 9.07 Net cash flow I'rom financing activities (C) 56.91 39.60 Net increase / (decrease) in cash and cash equivalents (A + B + C) 0.52 1.24 Cash and Cash Equivalents at the beginning of year 2.00 2.04 Cash and Cash Equivalents at the end of year 2.52' $.t8